Clinical Trials Logo

Clinical Trial Summary

Attention Deficit Hyperactivity Disorder (ADHD) is frequently associated with emotional dysregulation (ED). ED is characterized by excessive and inappropriate emotional reactions compared to social norms, uncontrolled and rapide shifts in emotion and attention focused on emotional stimuli. According to research, there are strong correlations between personality traits and psychiatric disorder as ADHD. In a longitudinal study, the persistence of ADHD symptoms during adolescence is associated with high neuroticism, low agreeableness and low conscience. Studies show that these personality traits are factors of vulnerabilities for comordities associated with ADHD and are predictive of overall functioning difficulties. Studies show correlations between ADHD in childhood and personality disorders at adulthood . ADHD is frequently associated with emotional dysregulation (ED) that is characterized by an inability to modulate emotional responses in a given context . ED is observed in 24% to 50% children with ADHD . Children with ADHD and ED are more likely to present a severe and complex symptomatology and are at risk for antisocial and bordeline personality disorders than children without ED. To date, there would be no studies which would have been interested in personality traits in children with ADHD and ED. The main objective is to determine if children with ADHD and ED present from childhood traits of personality as low agreeableness, low conscience and high neuroticism that are predictive of personality disorders at adulthood. It would involve earl identification of children at increased risk of pejorative developmental trajectories. The second objectives are: - Improve understanding of the heterogeneity of ADHD symptom expression; - Have a better understanding of the child's personalit and temperament traits to identify riks and protective factors; - Identify children with ADHD with profiles at risk of personality disorders in order to adapt the care according to the child's needs.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05096975
Study type Observational
Source University Hospital, Montpellier
Contact
Status Completed
Phase
Start date September 1, 2020
Completion date December 30, 2021

See also
  Status Clinical Trial Phase
Completed NCT01883817 - Effect of Omega-3 Fatty Acid on Cortical Function in ADHD Phase 3
Completed NCT03662763 - Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity Phase 3
Recruiting NCT01154686 - Working Memory Training in College Students With Attention-Deficit Hyperactivity Disorder/Learning Disabilities N/A
Unknown status NCT01130467 - Event-related Potentials in Management of Children With Attention-deficit/Hyperactivity Disorder Phase 4
Completed NCT04577417 - Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD
Completed NCT03948607 - Neural Mechanisms of Attention Lapses in Adult ADHD
Completed NCT06064942 - Multiple Family Narrative Therapy for Chinese Families of Children With Attention Deficit Hyperactivity Disorder N/A
Completed NCT06030024 - Efficacy of Repetitive Transcranial Magnetic Stimulation in Adult Attention Deficit Disorder N/A
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT02062411 - A Randomized Controlled Study of Cognitive Behavioral Therapy for Adults With Attention Deficit Disorder N/A
Completed NCT01000064 - Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits Phase 3
Completed NCT00048360 - Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults Phase 3
Completed NCT00776737 - Studies of Measures of Attention N/A
Recruiting NCT05243186 - Assessing Cognitive Performance Among Adults With Attention Disorders Working on Treadmill Phase 2/Phase 3
Recruiting NCT05133284 - Effectiveness of a Therapeutic Education Program in Improving Quality of Life of Children With ADHD and Their Parents
Completed NCT02635035 - Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT Phase 2
Completed NCT01369459 - Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder Phase 1
Recruiting NCT05406414 - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems N/A
Not yet recruiting NCT06248229 - A Trial of Dyanavel XR in Treating Co-occurring Fatigue Symptoms in Adults With Attention Deficit Hyperactivity Disorder (ADHD). Phase 4